Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Appyea (APYP) Research & Development (2024 - 2025)

Appyea filings provide 2 years of Research & Development readings, the most recent being $23000.0 for Q4 2025.

  • On a quarterly basis, Research & Development changed 0.0% to $23000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $269000.0, a 20.41% decrease, with the full-year FY2025 number at $240000.0, down 29.2% from a year prior.
  • Research & Development reached $23000.0 in Q4 2025 per APYP's latest filing, up from $2000.0 in the prior quarter.
  • The five-year high for Research & Development was $221000.0 in Q2 2025, with the low at $2000.0 in Q3 2025.